X4 Pharmaceuticals Files 2024 10-K
Ticker: XFOR · Form: 10-K · Filed: Mar 26, 2025 · CIK: 1501697
| Field | Detail |
|---|---|
| Company | X4 Pharmaceuticals, Inc (XFOR) |
| Form Type | 10-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotech
TL;DR
X4 Pharma dropped its 2024 10-K. Financials for 2024 are in, check it out.
AI Summary
X4 Pharmaceuticals, Inc. filed its 2024 10-K on March 26, 2025, detailing its financial performance and business operations for the fiscal year ending December 31, 2024. The company, formerly known as Arsanis, Inc., is focused on biological products and is headquartered in Boston, MA. The filing covers financial data from 2022 through 2024.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of X4 Pharmaceuticals' financial health and strategic direction for the past fiscal year, crucial for understanding its current market position and future prospects.
Risk Assessment
Risk Level: medium — As a company in the biological products sector, X4 Pharmaceuticals faces inherent risks related to research, development, regulatory approval, and market competition.
Key Numbers
- 2024 — Fiscal Year (The period covered by the 10-K filing.)
- 2022-2024 — Financial Data Range (The years for which financial information is provided in the filing.)
Key Players & Entities
- X4 Pharmaceuticals, Inc. (company) — Filer of the 10-K
- Arsanis, Inc. (company) — Former name of X4 Pharmaceuticals, Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-26 (date) — Filing date
- Boston, MA (location) — Company headquarters
FAQ
What is the primary business of X4 Pharmaceuticals, Inc.?
X4 Pharmaceuticals, Inc. is involved in the biological products sector, specifically 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' as indicated by SIC code 2836.
When was the company formerly known as?
The company was formerly known as Arsanis, Inc., with a date of name change on September 20, 2010.
What is the SEC file number for this filing?
The SEC file number for this 10-K filing is 001-38295.
Where is X4 Pharmaceuticals, Inc. located?
X4 Pharmaceuticals, Inc. is located at 61 North Beacon Street, 4th Floor, Boston, MA 02134.
What is the fiscal year end for X4 Pharmaceuticals, Inc.?
The fiscal year end for X4 Pharmaceuticals, Inc. is December 31 (1231).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 26, 2025 regarding X4 Pharmaceuticals, Inc (XFOR).